[HTML][HTML] In silico analyses of extracellular proteins of acinetobacter baumannii as immunogenic candidates

S Fereshteh, NN Goodarzi, A Sepehr… - Iranian Journal of …, 2022 - ncbi.nlm.nih.gov
Background Acinetobacter baumannii is an important nosocomial pathogen causing high
morbidity and mortality in immunocompromised patients with prolonged hospitalization …

In Silico Identification of Probable Drug and Vaccine Candidates Against Antibiotic-Resistant Acinetobacter baumannii

E Zadeh Hosseingholi, G Zarrini… - Microbial Drug …, 2020 - liebertpub.com
Acinetobacter baumannii is known as a Gram-negative bacterium that has become one of
the most important health problems due to antibiotic resistance. Today, numerous efforts are …

[PDF][PDF] Computational design of peptide vaccine against Acinetobacter baumannii infection using comparative genomic approach

AA Taiwo, AJ Falilat, YS Ezemuel - Comput. Biol. Bioinform, 2014 - researchgate.net
The bacterial species Acinetobacter baumannii is a major cause of hospital acquired
infection throughout the world and it is increasing public health concern. Infection caused by …

Comparative in silico analyses of proteins involved in serum resistance as promising vaccine candidates against Acinetobacter baumannii

A Soltani Shirazi, O Azizi, N Bolourchi… - Vaccine …, 2017 - vacres.pasteur.ac.ir
Introduction: Acinetobacter baumannii as a Gram-negative coccobacillus has become a
major cause of hospital-acquired infections. The virulence factors involved in serum …

In silico design and evaluation of acinetobacter baumannii outer membrane protein A (OmpA) antigenic peptides as vaccine candidate in immunized mice

K Mehdinejadiani, M Bandehpour… - Iranian Journal of …, 2019 - ijaai.tums.ac.ir
Acinetobacter baumannii is a Gram-negative bacterium that has recently been identified as
a leading nosocomial pathogen. Infections by this pathogen result in significant mortality due …

Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach

T Piri-Gharaghie, A Doosti, SA Mirzaei - Applied Biochemistry and …, 2022 - Springer
Multidrug-resistant Acinetobacter baumannii (A. baumannii) infections are becoming more
prevalent all over the world. As a cost-effective and preventative method, vaccination seems …

[HTML][HTML] In-Silico Vaccine Design Based on a Novel Vaccine Candidate Against Infections Caused by Acinetobacter baumannii

K Khalid, S Irum, SR Ullah, S Andleeb - International journal of peptide …, 2022 - Springer
Acinetobacter baumannii is notorious for causing serious infections of the skin, lungs, soft
tissues, bloodstream, and urinary tract. Despite the overwhelming information available so …

[PDF][PDF] In silico analysis of Acinetobacter baumannii outer membrane protein BamA as a potential immunogen

R Singh, N Garg, N Capalash, R Kumar… - Int J Pure Appl Sci …, 2014 - Citeseer
A. baumannii is an emerging nosocomial pathogen associated with health care units. Its
resistance to various antibiotics gives rise to the need of vaccine development against it …

In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of outer membrane protein A

A Jahangiri, I Rasooli, P Owlia, AAI Fooladi… - Microbial …, 2017 - Elsevier
Outer membrane protein A (OmpA) is the most promising vaccine candidate against one of
the most successful nosocomial pathogens, A. baumannii. Despite advantages of the …

Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb

N Garg, R Singh, G Shukla, N Capalash… - International Journal of …, 2016 - Elsevier
Acinetobacter baumannii is an emerging multi-drug resistant pathogen causing significant
mortality in hospitalized ICU patients which demands developing new methods for …